Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators.
Jiakai HouYunfei WangLeilei ShiYuan ChenChunyu XuArash SaeediKe PanRitu BohatNicholas A EganJodi A McKenzieRina M MbofungLeila J WilliamsZhenhuang YangMing SunXiaofang LiangJordi Rodon AhnertNavin VaradarajanCassian YeeYiwen ChenPatrick HwuWeiyi PengPublished in: Journal for immunotherapy of cancer (2022)
Collectively, the data provide a rich resource of novel targets for rational immuno-oncology combinations.